These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1697112)

  • 1. Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats.
    Woo J; Ross CS; Milton JI; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1642-4. PubMed ID: 1697112
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo.
    Zheng B; Shorthouse R; Masek MA; Berry G; Billingham ME; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):851-5. PubMed ID: 1703717
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of FK 506 on B-cell responses.
    Lagodziński Z; Górski A; Stepień-Sopniewska B; Wasik M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):942-3. PubMed ID: 1703359
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal.
    Woo J; Ross CS; Milton JI; Thomson AW
    Clin Exp Immunol; 1990 Jan; 79(1):109-14. PubMed ID: 1689226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506.
    Walliser P; Benzie CR; Kay JE
    Immunology; 1989 Nov; 68(3):434-5. PubMed ID: 2480331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interspecies comparison of the immunosuppressive efficacy and safety of FK 506.
    Thomson AW
    Transplant Proc; 1990 Feb; 22(1):100-5. PubMed ID: 1689883
    [No Abstract]   [Full Text] [Related]  

  • 9. FK 506 and cyclosporine A: early effects on activation and gene induction in mouse spleen cells.
    Metcalfe S; Milner J; Richards FM
    Transplant Proc; 1990 Aug; 22(4):1547-8. PubMed ID: 1697107
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function.
    Burckhardt JJ; Guggenheim B
    Immunology; 1979 Apr; 36(4):753-7. PubMed ID: 312270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malononitrilamides inhibit T- and B-cell responsiveness.
    Kurrle R; Bartlett R; Ruuth E; Lauffer L; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3053-6. PubMed ID: 8962184
    [No Abstract]   [Full Text] [Related]  

  • 12. Spleen lymphocyte populations and expression of activation markers in rats treated with the potent new immunosuppressive agent FK-506.
    Woo J; Stephen M; Thomson AW
    Immunology; 1988 Sep; 65(1):153-5. PubMed ID: 2460401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
    Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
    Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive activity, T-cell subset analysis, and acute toxicity of FK-506 in rats.
    Thomson AW; Stephen ME; Woo J; Hasan NU; Whiting PH
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1048-9. PubMed ID: 2468203
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction.
    Bierer BE; Schreiber SL; Burakoff SJ
    Transplantation; 1990 Jun; 49(6):1168-70. PubMed ID: 1694317
    [No Abstract]   [Full Text] [Related]  

  • 16. The mechanism of action of FK 506.
    Kay JE; Moore AL; Doe SE; Benzie CR; Schönbrunner R; Schmid FX; Halestrap AP
    Transplant Proc; 1990 Feb; 22(1):96-9. PubMed ID: 1689914
    [No Abstract]   [Full Text] [Related]  

  • 17. Pretreatment with lymphocyte subpopulations and renal allograft survival in the rat.
    Cranston D; Wood KJ; Carter N; Morris PJ
    Transplantation; 1987 Jun; 43(6):809-13. PubMed ID: 3296346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
    Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes.
    Fujii Y; Fujii S; Kaneko T
    Transplantation; 1989 Jun; 47(6):1081-3. PubMed ID: 2472025
    [No Abstract]   [Full Text] [Related]  

  • 20. [Functional activity of spleen and peripheral blood lymphocytes during stress-induced immunodepression].
    Iagmurov OD; Ogurtsov RP
    Biull Eksp Biol Med; 1996 Jul; 122(7):64-8. PubMed ID: 9303705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.